[1]杨 强,方 健,王海峰,等.促红细胞生成素治疗急性脊髓损伤的临床研究[J].医学信息,2018,31(11):70-72.[doi:10.3969/j.issn.1006-1959.2018.11.022]
　YANG Qiang,FANG Jian,WANG Hai-feng,et al.Clinical Study of Erythropoietin in the Treatment of Acute Spinal Cord Injury[J].Journal of Medical Information,2018,31(11):70-72.[doi:10.3969/j.issn.1006-1959.2018.11.022]
点击复制

促红细胞生成素治疗急性脊髓损伤的临床研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年11期
页码:
70-72
栏目:
论著
出版日期:
2018-06-01

文章信息/Info

Title:
Clinical Study of Erythropoietin in the Treatment of Acute Spinal Cord Injury
文章编号:
1006-1959（2018）11-0070-03
作者:
杨 强; 方 健; 王海峰; 李葛威; 王 涛
安徽医科大学解放军临床学院，安徽 合肥 230000
Author(s):
YANG Qiang; FANG Jian; WANG Hai-feng; LI Ge-wei; WANG Tao
PLA Clinical College,Medical University of Anhui,Hefei 230000,Anhui,China
关键词:
急性脊髓损伤; 甲强龙; 冲击疗法; 促红细胞生成素
Keywords:
Key words：Acute spinal cord injury; Methylprednisolone; Shock therapy; Erythropoietin
分类号:
R683.2
DOI:
10.3969/j.issn.1006-1959.2018.11.022
文献标志码:
A
摘要:
目的 分析大剂量甲强龙联合促红细胞生成素治疗急性脊髓损伤患者的临床疗效。方法 选取2016年1月~2017年6月就诊于我院骨科的56例ASCI患者,采用控制主要因素的分层随机化分组法和简单随机分组法，将患者分为观察组与对照组，每组26例，观察组给予MP+EPO治疗，对照组给予MP治疗,并在患者收治入院时及治疗后1、6个月，严格按照ASIA评分标准，对患者的脊髓神经功能进行评定，并记录并发症情况。结果 与入院时相比，治疗后1月及6个月两组患者ASIA评分提高，差异有统计学意义(P＜0.05), 且观察组高于对照组，差异有统计学意义(P＜0.05)。两组患者并发症比较，差异无统计学意义（P＞0.05）。结论 MP冲击疗法联合EPO治疗ASCI比单用MP治疗效果更佳，EPO能有效促进ASCI患者的神经功能恢复。
Abstract:
Abstract：Objective To analyze the clinical efficacy of large dose methylprednisolone combined with erythropoietin in the treatment of acute spinal cord injury.Methods 56 patients with ASCI who were treated in our department of orthopaedics from January 2016 to June 2017 were selected.Stratified randomization and simple randomization methods were used to control the main factors.The patients were divided into observation group and control group.In the group of 26 patients,the observation group was given MP+EPO treatment, and the control group was given MP treatment.The spinal cord nerve function of the patient was assessed and the complications were recorded on the admission of the patient and 1,6 months after treatment,in strict accordance with the ASIA score.Results Compared with the time of admission,the ASIA scores of the two groups were increased at the 1st and 6th month after treatment,the difference was statistically significant(P<0.05),and the observation group was higher than the control group,the difference was statistically significant(P<0.05).There was no significant difference in complications between the two groups(P>0.05).Conclusion MP shock therapy combined with EPO treatment of ASCI is more effective than MP alone,and EPO can effectively promote the recovery of neurological function in patients with ASCI.

参考文献/References:

[1]Witiw C D,Fehlings M G.Acute spinal cord injury[J].Clinical Spine Surgery,2015,28(6):202-210. [2]Celik B,Ones K,Celik E C,et al.The effects of using the internet on the health-related quality of life in people with spinal cord injury:a controlled study[J].Spinal cord,2014,52(5):388. [3]罗坤烈,陆茂德,仇继任,等.大剂量甲强龙、外科减压及两者联合治疗颈椎无骨折脱位脊髓损伤的临床研究[J].临床医学,2016,36(3):55-56. [4]王鹏,孙桂森,郭隆升,等.急性脊髓损伤的药物治疗[J].医学与哲学(B),2017,38(6):72-75. [5]Maiese K.Regeneration in the nervous system with erythropoietin[J].Frontiers in bioscience (Landmark edition),2016,21(3):561. [6]鞠飞,赵海苹,罗玉敏.促红细胞生成素在神经系统疾病治疗中的临床研究[J].实用药物与临床,2017,20(03):339-344. [7]Harvey L,Graves D.International Standards for the Neurological Classification of Spinal Cord Injury[J].Journal of physiotherapy,2011,57(2):129. [8]Frankel脊髓损伤分级[J].临床神经外科杂志,2010,7(02):97. [9]曹鹏,石长贵,袁文.甲基强的松龙在急性脊髓损伤中的应用进展[J].中国脊柱脊髓杂志，2015,25(2):174-178. [10]Zhang Q,Huang C,Tang T,et al.Comparative neuroprotective effects of methylprednisolone and rosiglitazone,a peroxisome proliferator-activated receptor-gamma following spinal cord injury[J].Neurosciences(Riyadh),2011,16(1):46-52. [11]Evaniew N,Belley-Cté E P,Fallah N,et al.Methylprednisolone for the treatment of patients with acute spinal cord injuries:a systematic review and meta-analysis[J].Journal of neurotrauma,2016,33(5):468-481. [12]Li Z,Xiao Y,Zhu J,et al.Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury:a randomized,double blind and controlled clinical trial[J].Clinical neurology and neurosurgery,2016(150):80-83. [13]Tsai T H,Lu C H,Wallace C G,et al.Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients:a randomized,prospective,placebo-controlled clinical trial[J].Critical Care,2015,19(1):49. [14]Yao X,Wang D,Li H,et al.Erythropoietin Treatment in Patients with Acute Ischemic Stroke:A Systematic Review and Meta-Analysis of Randomized Controlled Trials[J].Current Drug Delivery,2017,14(6):853-860. [15]Li X,Bai Z Y,Zhang F Y,et al.[Neuroprotection of herbs promoting EPO on cerebral ischemia][J].China Journal of Chinese Materia Medica,2015,40(12):2265.

更新日期/Last Update: 2018-06-01